Luong V. Dinh
Hanoi, Viet Nam
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Depressive symptoms and their associations with tuberculosis-related knowledge, attitudes, and practices among patients with multidrug-resistant tuberculosis.
Journal: Frontiers in public health
Published: April 09, 2026
Diagnostic accuracy and potential resource savings of pooled sputum testing with Xpert MTB/RIF Ultra for tuberculosis among adults in Vietnam: a cross-sectional study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 31, 2026
Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis.
Journal: The European respiratory journal
Published: September 04, 2025
Bridging the analog divide: a comparison of printed X-ray films and digital images when using computer-aided detection software for tuberculosis screening.
Journal: BMC global and public health
Published: August 28, 2025
Clinical, imaging, bronchoscopic characteristics and pulmonary function features in patients with endobronchial tuberculosis: a single-centre cross-sectional study.
Journal: BMJ open respiratory research
Published: August 28, 2025
Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis.
Journal: Clinical pharmacokinetics
Published: July 25, 2025
Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva.
Journal: Clinical pharmacokinetics
Published: July 25, 2025
Effectiveness of individualized nutritional support in improving clinical symptoms of patients with acute exacerbations of chronic obstructive pulmonary disease: a pre-post intervention study.
Journal: Journal of thoracic disease
Published: June 23, 2025
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: March 29, 2025
Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study.
Journal: Infectious diseases of poverty
Published: December 08, 2023
Last Updated: 09/26/2026